Ryan D. Lake
2022 - Recro Pharma
In 2022, Ryan D. Lake earned a total compensation of $1.4M as Chief Financial Officer at Recro Pharma, a 39% decrease compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $279,431 |
| Salary | $438,269 |
| Stock Awards | $419,999 |
| Other | $52,993 |
| Total | $1,415,692 |
Lake received $438.3K in salary, accounting for 31% of the total pay in 2022.
Lake also received $225K in bonus, $279.4K in option awards, $420K in stock awards and $53K in other compensation.
Rankings
In 2022, Ryan D. Lake's compensation ranked 2,326th out of 5,534 executives tracked by ExecPay. In other words, Lake earned more than 58.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,326 out of 5,534 | 58th |
Division Manufacturing | 1,265 out of 3,000 | 58th |
Major group Chemicals And Allied Products | 563 out of 1,350 | 58th |
Industry group Drugs | 518 out of 1,253 | 59th |
Industry Pharmaceutical Preparations | 372 out of 907 | 59th |
Source: SEC filing on April 6, 2023.
Lake's colleagues
We found one more compensation record of an executive who worked with Ryan D. Lake at Recro Pharma in 2022.
2022
J Enloe
Recro Pharma
Chief Executive Officer
News
Recro Pharma CEO J Enloe's 2022 pay jumps 107% to $2.3M
April 6, 2023
Recro Pharma CFO Ryan Lake's 2021 pay jumps 622% to $2.3M
April 1, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020